310 404

Cited 0 times in

A New Treatment Strategy for Asthma : SMART (Symbicort(R) Maintenance And Reliever Therapy)

Other Title
천식의 약물치료 : 스마트요법
박, 해심; 예, 영민
Taehan Ŭisa Hyŏphoe chi, 50(3):279-283, 2007
Journal Title
Taehan Ŭisa Hyŏphoe chi; Journal of the Korean Medical Association; 대한의사협회지
Asthma is characterized by chronic inflammation of the airways with variable airflow limitation resulting in recurrent wheezing, chest tightness, and cough. Long term management is essential to prevent symptom and asthma exacerbation with using daily controller medications. Asthma control was much improved by combining inhaled corticosteroids with long-acting β2 agonists. Recent several studies demonstrated the effectiveness of a new asthma management strategy, a single inhaler containing budesonide and formoterol for both maintenance therapy and symptom relief (called SMART) which was approved in GINA guideline, 2006. This SMART strategy could reduce the frequency of severe exacerbations and the need for rescue medicine with systemic steroids as well as improved lung function and asthma controls at relatively lower doses of corticosteroid with lesser costs for treatment.
AsthmaICS and LABA combinationSMART
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Allergy
AJOU Authors
박, 해심
Full Text Link
Files in This Item:
Journal of the Korean Medical Association_50(3)_279-283.pdfDownload
RIS (EndNote)
XLS (Excel)


해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.